Merck & Co., Inc. - MRK Stock Forecast, Price & News

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merck & Co., Inc. in the last twelve months. There are currently 8 hold ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Merck & Co., Inc. stock.
View analyst ratings for Merck & Co., Inc. or view top-rated stocks.

18 Wall Street research analysts have issued 12 month price objectives for Merck & Co., Inc.'s shares. Their MRK stock forecasts range from $85.00 to $110.00. On average, they expect Merck & Co., Inc.'s share price to reach $97.44 in the next year. This suggests a possible upside of 11.5% from the stock's current price.
View analysts' price targets for Merck & Co., Inc. or view top-rated stocks among Wall Street analysts.

Merck & Co., Inc.'s stock was trading at $76.64 at the start of the year. Since then, MRK shares have increased by 14.1% and is now trading at $87.41.
View the best growth stocks for 2022 here.

Merck & Co., Inc. is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our earnings forecast for Merck & Co., Inc..

Merck & Co., Inc. (NYSE:MRK) announced its earnings results on Thursday, July, 28th. The company reported $1.87 earnings per share for the quarter, beating analysts' consensus estimates of $1.69 by $0.18. The company had revenue of $14.59 billion for the quarter, compared to analysts' expectations of $13.85 billion. Merck & Co., Inc. had a net margin of 29.00% and a trailing twelve-month return on equity of 50.02%. Merck & Co., Inc.'s quarterly revenue was up 28.0% on a year-over-year basis. During the same period last year, the business posted $1.31 EPS.

Merck & Co., Inc. declared a quarterly dividend on Tuesday, July 26th. Shareholders of record on Thursday, September 15th will be paid a dividend of $0.69 per share on Friday, October 7th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 3.16%. The ex-dividend date of this dividend is Wednesday, September 14th.
View Merck & Co., Inc.'s dividend history.

Merck & Co., Inc.(NYSE:MRK) pays an annual dividend of $2.76 per share and currently has a dividend yield of 3.16%. Merck & Co., Inc. has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Merck & Co., Inc. is 42.27%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Merck & Co., Inc. will have a dividend payout ratio of 38.39% next year. This indicates that Merck & Co., Inc. will be able to sustain or increase its dividend.
View Merck & Co., Inc.'s dividend history.

Merck & Co., Inc. issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $7.25-$7.35 for the period, compared to the consensus EPS estimate of $7.36. The company issued revenue guidance of $57.50 billion-$58.50 billion, compared to the consensus revenue estimate of $58.10 billion.

1,343 employees have rated Merck & Co., Inc. CEO Kenneth C. Frazier on Glassdoor.com. Kenneth C. Frazier has an approval rating of 94% among Merck & Co., Inc.'s employees. This puts Kenneth C. Frazier in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Merck & Co., Inc. investors own include Pfizer (PFE), Johnson & Johnson (JNJ), AT&T (T), Intel (INTC), Cisco Systems (CSCO), Walt Disney (DIS), Verizon Communications (VZ), JPMorgan Chase & Co. (JPM), AbbVie (ABBV) and Home Depot (HD).

Merck & Co., Inc. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRK."

Merck & Co., Inc.'s stock is owned by a number of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.33%), Envestnet Asset Management Inc. (0.24%), Truist Financial Corp (0.20%), DekaBank Deutsche Girozentrale (0.20%), Robeco Institutional Asset Management B.V. (0.16%) and Sarasin & Partners LLP (0.15%). Company insiders that own Merck & Co., Inc. stock include Caroline Litchfield, Frank Clyburn, Julie L Gerberding, Kenneth C Frazier, Richard R Deluca, Rita A Karachun, Robert M Davis, Sanat Chattopadhyay and Wendell P Weeks.
View institutional ownership trends for Merck & Co., Inc..

Shares of MRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MRK stock can currently be purchased for approximately $87.41.

Merck & Co., Inc. (NYSE:MRK) has a market capitalization of $221.04 billion and generates $48.70 billion in revenue each year. The company earns $13.05 billion in net income (profit) each year or $6.53 on an earnings per share basis.

Merck & Co., Inc. employs 68,000 workers across the globe.

Merck & Co., Inc. was founded in 1891.

Merck & Co., Inc.'s mailing address is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. The official website for Merck & Co., Inc. is www.merck.com. The company can be reached via phone at (908) 740-4000, via email at investor_relations@merck.com, or via fax at 908-735-1253.